The 14-3-3 proteins are a family of conserved regulatory molecules expressed in all eukaryotic cells. A striking feature of the 14-3-3 proteins is their ability to bind a multitude of functionally diverse molecules. More than seventy proteins have been found to interact with 14-3-3, including kinases, phosphatases, transmembrane receptors, and transcription factors. This allows 14-3-3 to play important roles in a wide range of vital regulatory processes, such as Bad-induced apoptosis, Raf-1 -mediated cell proliferation, and Cdc25-regulated cell cycle progression. Thus, understanding the mechanisms that control the interaction of 14-3-3 with its target proteins will provide critical insight into more general questions concerning the control of intracellular signal transduction. This competing continuation application builds on our extensive experience with 14-3-3 proteins and recent new findings to test the hypothesis that one mechanism that regulates 14-3-3 function is phosphorylation of 14-3-3 proteins themselves. The main goals of the proposed research are: (i) To test the hypothesis that 14-3-3 proteins are subject to regulated phosphorylation. Phosphorylation sites of 14-3-3 isoforms will be mapped and kinases that are critical for phosphorylating these defined sites will be identified and characterized. (ii) To determine the mechanisms by which phosphorylation regulates 14-3-3/ ligand interactions. A selected inducible site will be used as a model system to test the effect of phosphorylation on 14-3-3/ ligand interactions and on 14-3-3 regulated Bad induced apoptosis. (iii) To determine and analyze the three-dimensional co-crystal structure of 14-3-3 with phosphorylated Bad protein and so provide a molecular explanation for the role of phosphorylation in 14-3-3 regulation. Because 14-3-3 often binds proteins, such as Bad, that lie at points of crosstalk between different signaling pathways, 14-3-3 binding may serve as a switch for critical cellular functions. Detailed understanding of the mechanism that controls 14-3-3/ ligand interactions may lead to novel strategies for therapeutic interventions against a variety of diseases such as human cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM053165-06A2
Application #
6543770
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Flicker, Paula F
Project Start
1996-05-01
Project End
2006-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
6
Fiscal Year
2002
Total Cost
$311,656
Indirect Cost
Name
Emory University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Du, Yuhong (2015) Fluorescence polarization assay to quantify protein-protein interactions in an HTS format. Methods Mol Biol 1278:529-44
Cockrell, L M; Puckett, M C; Goldman, E H et al. (2010) Dual engagement of 14-3-3 proteins controls signal relay from ASK2 to the ASK1 signalosome. Oncogene 29:822-30
Kasinski, Andrea L; Du, Yuhong; Thomas, Shala L et al. (2008) Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin. Mol Pharmacol 74:654-61
Li, Zenggang; Zhao, Jing; Du, Yuhong et al. (2008) Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci U S A 105:162-7
Luhn, Patricia; Wang, Haining; Marcus, Adam I et al. (2007) Identification of FAKTS as a novel 14-3-3-associated nuclear protein. Proteins 67:479-89
Du, Yuhong; Masters, Shane C; Khuri, Fadlo R et al. (2006) Monitoring 14-3-3 protein interactions with a homogeneous fluorescence polarization assay. J Biomol Screen 11:269-76
Porter, Gavin W; Khuri, Fadlo R; Fu, Haian (2006) Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin Cancer Biol 16:193-202
Sun, Shi-Yong; Rosenberg, Laura M; Wang, Xuerong et al. (2005) Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res 65:7052-8
Hamaguchi, Akikazu; Suzuki, Erika; Murayama, Kimie et al. (2003) Sphingosine-dependent protein kinase-1, directed to 14-3-3, is identified as the kinase domain of protein kinase C delta. J Biol Chem 278:41557-65
Hamaguchi, Akikazu; Suzuki, Erika; Murayama, Kimie et al. (2003) A sphingosine-dependent protein kinase that specifically phosphorylates 14-3-3 (SDK1) is identified as the kinase domain of PKCdelta: a preliminary note. Biochem Biophys Res Commun 307:589-94